SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Syschem (India) informs about outcome of board meeting

07 Jun 2023 Evaluate
Syschem (India) has informed that the Board of Directors at their meeting held today, 15th May, 2023 have considered and approved the following business: The Audited Financial Results of the company for the quarter and year ended 31st March, 2023 along with Audit Report issued by the Statutory Auditors of the Company; In compliance with Regulation 39(3) of SEBI (LODR) Regulations, 2015, The Board of director of the company has also approved the issuance of duplicate share certificates to the shareholders and the details of the same as enclosed.

The above information is a part of company’s filings submitted to BSE.

Syschem (India) Share Price

52.87 0.74 (1.42%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×